J Physiol Society Meetings
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on November 4, 2004.
Copyright © 2004 by The Physiological Society
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
562/3/801    most recent
jphysiol.2004.075432v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valverde, C. A
Right arrow Articles by Mattiazzi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valverde, C. A
Right arrow Articles by Mattiazzi, A.

Received September 9, 2004
Revised October 13, 2004
Accepted after revision October 21, 2004

Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation

Carlos A Valverde1, Cecilia Mundiña-Weilenmann2, Matilde Said2, Paola Ferrero2, Leticia Vittone2, Margarita Salas2, Julieta Palomeque2, Martin Vila Petroff2, and Alicia Mattiazzi2*

1 Centro de Investigaciones Cardiovasculares. Facultad de Ciencias Medicas. UNLP
2 Centro de Investigaciones Cardiovasculares

* To whom correspondence should be addressed. E-mail: ramattia{at}atlas.med.unlp.edu.ar.

An increase in stimulation frequency causes an acceleration of myocardial relaxation (FDAR). Several mechanisms have been postulated to explain this effect, among which is the CaMKII-dependent phosphorylation of the Thr17 site of phospholamban (PLN). To gain further insights into the mechanisms of FDAR, we studied the FDAR and the phosphorylation of PLN residues in perfused rat hearts, cat papillary muscles and isolated myocytes. This allowed us to sweep over a wide range of frequencies, in species with either positive or negative force-frequency relationships, as well as to explore the FDAR under isometric (or isovolumic) and isotonic conditions. Results were compared with those produced by isoproterenol, an intervention known to accelerate relaxation (IDAR) via PLN phosphorylation. Whereas IDAR occurs tightly associated with a significant increase in the phosphorylation of Ser16 and Thr17 of PLN, FDAR occurs without significant changes in the phosphorylation of PLN residues in the intact heart and cat papillary muscles. Moreover, in intact hearts, FDAR was not associated with any significant change in the CaMKII-dependent phosphorylation of SERCA2a, and was not affected by the presence of the CaMKII inhibitor, KN-93. In isolated myocytes, FDAR occurred associated with an increase in Thr17 phosphorylation. However for a similar relaxant effect produced by isoproterenol, the phosphorylation of PLN (Ser16 + Thr17) was significantly higher in the presence of the {beta}-agonist. Moreover, the time course of Thr17 phosphorylation was significantly delayed with respect to the onset of FDAR. In contrast, the time course of Ser16 phosphorylation, the first residue that becomes phosphorylated with isoproterenol, was temporally associated with IDAR. Furthermore, KN-93, significantly decreased the phosphorylation of Thr17 evoked by increasing stimulation frequency, but failed to affect FDAR. Taken together, the results provide direct evidence indicating that CaMKII-phosphorylation pathways are not involved in FDAR and that FDAR and IDAR do not share a common underlying mechanism. More likely, a CaMKII-independent mechanism, whereby increasing stimulation frequency would disrupt the SERCA2a-PLN interaction, leading to an increase in SR Ca2+ uptake and myocardial relaxation could be involved.


Key words: Heart rate • protein phosphorylation • Relaxation




This article has been cited by other articles:


Home page
Biophys. JHome page
H. Chiba, N. S. Schneider, S. Matsuoka, and A. Noma
A Simulation Study on the Activation of Cardiac CaMKII {delta}-Isoform and Its Regulation by Phosphatases
Biophys. J., September 1, 2008; 95(5): 2139 - 2149.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. A. Werdich, E. A. Lima, I. Dzhura, M. V. Singh, J. Li, M. E. Anderson, and F. J. Baudenbacher
Differential effects of phospholamban and Ca2+/calmodulin-dependent kinase II on [Ca2+]i transients in cardiac myocytes at physiological stimulation frequencies
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2352 - H2362.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
N. MacQuaide, J. Dempster, and G. L. Smith
Measurement and Modeling of Ca2+ Waves in Isolated Rabbit Ventricular Cardiomyocytes
Biophys. J., October 1, 2007; 93(7): 2581 - 2595.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. Szentandrassy, M. R. Perez-Bido, E. Alonzo, N. Negretti, and S. C. O'Neill
Protein kinase A is activated by the n-3 polyunsaturated fatty acid eicosapentaenoic acid in rat ventricular muscle
J. Physiol., July 1, 2007; 582(1): 349 - 358.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Varian and P. M. L. Janssen
Frequency-dependent acceleration of relaxation involves decreased myofilament calcium sensitivity
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2212 - H2219.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. S. Maier and D. M. Bers
Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart
Cardiovasc Res, March 1, 2007; 73(4): 631 - 640.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Mattiazzi, L. Vittone, and C. Mundina-Weilenmann
Ca2+/calmodulin-dependent protein kinase: A key component in the contractile recovery from acidosis
Cardiovasc Res, March 1, 2007; 73(4): 648 - 656.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. J. Babu, P. Bhupathy, N. N. Petrashevskaya, H. Wang, S. Raman, D. Wheeler, G. Jagatheesan, D. Wieczorek, A. Schwartz, P. M. L. Janssen, et al.
Targeted Overexpression of Sarcolipin in the Mouse Heart Decreases Sarcoplasmic Reticulum Calcium Transport and Cardiac Contractility
J. Biol. Chem., February 17, 2006; 281(7): 3972 - 3979.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Mattiazzi, C. Mundina-Weilenmann, C. Guoxiang, L. Vittone, and E. Kranias
Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions
Cardiovasc Res, December 1, 2005; 68(3): 366 - 375.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 The Physiological Society.